Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor

CDX-622 - Celldex

https://eaaci2026.process.y-congress.com/ScientificProcess/schedule/?sessionGuid=34994413-3fed-4b16-b2de-de335c5d78ce&setLng=en

D. Alvarado1; D. Maurer1; J. Goldstein1; LJ. Thomas1; T. Hawthorne1; N. Sinclair1; M. Meltzer-Podolske1; H. Dunning1; T. Keler1; B. Bloom1; D. Young1; M. Valentine2

Apr 27, 2026